Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVID-19 Vaccine in HIV Patients
NCT05085145Phase 4Unknown
- Sponsor
- The Fifth Medical Center of the PLA General Hospital
- Start
- Sep 2021
- Primary completion
- Sep 2022
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in coronavirus disease 2019 (COVID-19), sponsored by The Fifth Medical Center of the PLA General Hospital. Primary endpoints: The occurence of adverse effects of COVID-19 vaccine at 2 months and The immunogenicity and persistence after COVID-19 vaccination at 2 months. Status: unknown.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05085145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05085145.